Nature Communications (Jun 2022)

A multi-ethnic polygenic risk score is associated with hypertension prevalence and progression throughout adulthood

  • Nuzulul Kurniansyah,
  • Matthew O. Goodman,
  • Tanika N. Kelly,
  • Tali Elfassy,
  • Kerri L. Wiggins,
  • Joshua C. Bis,
  • Xiuqing Guo,
  • Walter Palmas,
  • Kent D. Taylor,
  • Henry J. Lin,
  • Jeffrey Haessler,
  • Yan Gao,
  • Daichi Shimbo,
  • Jennifer A. Smith,
  • Bing Yu,
  • Elena V. Feofanova,
  • Roelof A. J. Smit,
  • Zhe Wang,
  • Shih-Jen Hwang,
  • Simin Liu,
  • Sylvia Wassertheil-Smoller,
  • JoAnn E. Manson,
  • Donald M. Lloyd-Jones,
  • Stephen S. Rich,
  • Ruth J. F. Loos,
  • Susan Redline,
  • Adolfo Correa,
  • Charles Kooperberg,
  • Myriam Fornage,
  • Robert C. Kaplan,
  • Bruce M. Psaty,
  • Jerome I. Rotter,
  • Donna K. Arnett,
  • Alanna C. Morrison,
  • Nora Franceschini,
  • Daniel Levy,
  • the NHLBI Trans-Omics in Precision Medicine (TOPMed) Consortium,
  • Tamar Sofer

DOI
https://doi.org/10.1038/s41467-022-31080-2
Journal volume & issue
Vol. 13, no. 1
pp. 1 – 13

Abstract

Read online

Polygenic risk scores have potential to predict an individual’s risk of disease based on genetic markers. Here, the authors develop a polygenic risk score for hypertension and test it in a multi-ethnic cohort, finding that the score is associated with higher likelihood of hypertension development 4-6 years later.